Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

For patients with coronary artery disease, the reduced rate of progression of atherosclerosis associated with intensive statin treatment, as compared with moderate statin treatment, is significantly related to greater reductions in the levels of both atherogenic lipoproteins and CRP.